Brief: Lipocine Regains Compliance With Minimum Bid Price Requirement
31/05/2023 22:34
May 31 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE - ON MAY 30, RECEIVED LETTER FROM NASDAQ STATING
CO HAD
REGAINED COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy